RNA sequencing of the MYCN-amplified NLF cells with and without YAP knockout treated with vehicle or trametinib showed that YAP mediates trametinib resistance through the transcriptional activation of E2F and MYCN, allowing the maintenance of the proliferative capacity of neuroblastoma cells [52]. Here, YAP1 is linked to neuroblastoma.